Antibody Therapeutics Patients First!

공지사항

PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited as a chairman of the session of the antibody therapeutics at BIOPLUS 2018 on September 6-9, 2018.
  • 글쓴이 관리자
  • 작성일 2018-08-06 13:25:53
  • 조회수 51

PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited as a chairman of the session of the antibody therapeutics at BIOPLUS 2018 (https://bioplus.kr/fairDash.do?hl=ENG) on September 6-9, 2018.

 

 

For investors attending the BIOPLUS 2018, please contact PharmAbcine Investor Relations and business development to schedule a meeting with management at sungwoo.kim@pharmabcine.com.

 

목록





이전글 PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. ...
다음글 PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. ...